Analyst Target Downside
Analyst Downside Risks – Page 8
Stocks where analyst target estimates imply downside from the current market price.
Showing 169–192 of 256 stocks
Page 8 of 11
Data as of
Nov 6, 2026
Criteria
A positive analyst price target and negative target gap are required; $100M+ market cap applies by default.
Ranking
Major U.S. listings and broader analyst coverage first, then bounded analyst-implied downside.
Data quality
Validated results require usable primary evidence and apply sector-appropriate quality checks; unavailable supporting metrics remain neutral rather than becoming zero.
Strong favorable
Favorable
Watch
Risk / negative
Neutral
↔ Scroll horizontally to compare all relevant metrics Swipe horizontally to compare all relevant metrics
Rank
Ticker
Market
Analyst Upside
Buy Consensus
Coverage
Fair Value Gap
P/E
Health
Market Cap
#169
DNUT
NASDAQ
-9.1% Downside
33.3% Buy
Mixed
6
ratings
-34.3% Downside
Overvalued
—
Fair
$798.10M
#170
ERIC
NASDAQ
-8.8% Downside
0.0% Buy
Mixed
5
ratings
19.1% Upside
Undervalued
17.4x
Good
$34.21B
#171
BOX
NYSE
-8.5% Downside
42.9% Buy
Mixed
7
ratings
-5.7% Downside
Fair
59.5x
Good
$5.98B
#172
MD
NYSE
-8.4% Downside
14.3% Buy
Mixed
7
ratings
10.1% Upside
Fair
16.2x
Great
$2.43B
#173
ANDG
NYSE
-8.2% Downside
62.5% Buy
Buy
8
ratings
28.1% Upside
Undervalued
28.6x
Great
$7.48B
#174
VSTS
NYSE
-7.9% Downside
33.3% Buy
Mixed
6
ratings
-14.5% Downside
Fair
—
Fair
$1.87B
#175
RSKD
NYSE
-7.9% Downside
50.0% Buy
Buy
6
ratings
9.4% Upside
Fair
—
Good
$1.10B
#176
PCRX
NASDAQ
-7.8% Downside
0.0% Buy
Mixed
9
ratings
31.1% Upside
Undervalued
99.2x
Great
$1.45B
#177
TASK
NASDAQ
-7.4% Downside
25.0% Buy
Mixed
8
ratings
34.3% Upside
Undervalued
8.2x
Great
$841.70M
#178
ECPG
NASDAQ
-7.3% Downside
66.7% Buy
Buy
3
ratings
-16.9% Downside
Fair
7.5x
Great
$2.64B
#179
ULCC
NASDAQ
-7.1% Downside
0.0% Buy
Mixed
9
ratings
14.1% Upside
Fair
—
Fair
$1.64B
#180
IPAR
NASDAQ
-6.5% Downside
33.3% Buy
Mixed
6
ratings
-3.0% Downside
Fair
25.5x
Great
$4.33B
#181
DBX
NASDAQ
-6.3% Downside
0.0% Buy
Mixed
6
ratings
21.4% Upside
Undervalued
17.6x
Great
$7.78B
#182
FHI
NYSE
-6.3% Downside
14.3% Buy
Mixed
7
ratings
19.1% Upside
Undervalued
11.3x
Great
$4.51B
#183
HZO
NYSE
-6.3% Downside
11.1% Buy
Mixed
9
ratings
-30.4% Downside
Overvalued
—
Fair
$1.17B
#184
HRB
NYSE
-6.1% Downside
0.0% Buy
Mixed
4
ratings
36.1% Upside
Undervalued
9.3x
Great
$6.78B
#185
ATRC
NASDAQ
-6.1% Downside
57.1% Buy
Buy
7
ratings
-24.3% Downside
Overvalued
209.7x
Great
$3.12B
#186
HMC
NYSE
-6.0% Downside
33.3% Buy
Mixed
3
ratings
3.1% Upside
Fair
—
Fair
$47.89B
#187
SMA
NYSE
-6.0% Downside
55.6% Buy
Buy
9
ratings
-34.4% Downside
Overvalued
76.2x
Good
$2.14B
#188
GRBK
NYSE
-5.9% Downside
0.0% Buy
Mixed
3
ratings
4.5% Upside
Fair
10.4x
Good
$2.80B
#189
TBBB
NYSE
-5.8% Downside
75.0% Buy
Strong Buy
8
ratings
-26.9% Downside
Overvalued
—
Good
$8.12B
#190
BDN
NYSE
-5.4% Downside
0.0% Buy
Mixed
4
ratings
7.1% Upside
Fair
—
Fair
$540.70M
#191
GPK
NYSE
-5.1% Downside
11.1% Buy
Mixed
9
ratings
33.7% Upside
Undervalued
46.2x
Good
$3.42B
#192
IHS
NYSE
-5.1% Downside
33.3% Buy
Mixed
3
ratings
20.4% Upside
Undervalued
5.0x
Good
$2.84B
No company or ticker on this page matches your search.